American CryoStem Announces Receipt of Key Business Method Patent for its Cellular Platform

Author's Avatar
Apr 12, 2019
Article's Main Image

EATONTOWN, NJ / ACCESSWIRE / August 21, 2018 /American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced receipt of Patent No. US 10,014,079 B2 "Business Method for Collecting, Processing, Cryogenic Storage, and Distribution of a Biologic Sample Material"from the U.S. Patent and Trademark Office (USPTO) for U.S. patent application 13/702.304 covering the Company's methods of Collection, Processing, Cryogenic Storage and Distribution of adipose tissue and adipose derived stem cells.